Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

Growth Factor ◽

Epidermal Growth Factor ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Metastatic Pancreatic Cancer ◽

Epidermal Growth ◽

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

Investigational New Drugs ◽

10.1007/s10637-010-9619-8 ◽

2010 ◽

Vol 30 (3) ◽

pp. 1138-1143 ◽

Cited By ~ 40

Author(s):

Dirk Strumberg ◽

Beate Schultheis ◽

M. E. Scheulen ◽

R. A. Hilger ◽

J. Krauss ◽

...

Keyword(s):

Pancreatic Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1383-0 ◽

2010 ◽

Vol 67 (4) ◽

pp. 891-897 ◽

Cited By ~ 19

Author(s):

J. P. Arnoletti ◽

A. Frolov ◽

M. Eloubeidi ◽

K. Keene ◽

J. Posey ◽

...

Keyword(s):

Pancreatic Cancer ◽

Growth Factor ◽

Phase I Study ◽

Locally Advanced ◽

Advanced Pancreatic Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

732 POSTER Phase I clinical study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody (Nimotuzumab) in combination with chemotherapy in patients with locally-advanced breast cancer. Preliminary results

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70531-1 ◽

2007 ◽

Vol 5 (4) ◽

pp. 116-117 ◽

Cited By ~ 3

Author(s):

J. Soriano ◽

N. Batista ◽

M. Lima ◽

R. Rodríguez ◽

M.V. López ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Epidermal growth factor receptor-targeted therapy for pancreatic cancer

Seminars in Oncology ◽

10.1053/sonc.2002.35645 ◽

2002 ◽

Vol 29 (5 Suppl 14) ◽

pp. 31-37 ◽

Cited By ~ 80

Author(s):

Henry Q. Xiong ◽

James L. Abbruzzese

Keyword(s):

Pancreatic Cancer ◽

Targeted Therapy ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Faculty Opinions recommendation of Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5232959.5173058 ◽

2010 ◽

Author(s):

Jacques Bernier

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Head And Neck ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Advanced Head ◽

Epidermal Growth ◽

Receptor Inhibitor

Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance

PLoS ONE ◽

10.1371/journal.pone.0192927 ◽

2018 ◽

Vol 13 (2) ◽

pp. e0192927

Author(s):

Alexey V. Danilov ◽

Divas Neupane ◽

Archana Sidalaghatta Nagaraja ◽

Elena V. Feofanova ◽

Leigh Ann Humphries ◽

...

Keyword(s):

Pancreatic Cancer ◽

Growth Factor ◽

Cell Growth ◽

Epidermal Growth Factor ◽

Cancer Cell ◽

Pancreatic Cancer Cell ◽

Growth Factor Receptor ◽

Cancer Cell Growth ◽

10 Incidence of mutations in the epidermal growth factor receptor (EGFR) in Wrexham area patients with metastatic and locally advanced non-sqamous cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(13)70010-2 ◽

2013 ◽

Vol 79 ◽

pp. S4

Author(s):

A. Gostage ◽

G. Drury ◽

N. McAndrew ◽

S. Kelly ◽

M. Steel ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Growth Factor Receptor ◽

PANC-1 Pancreatic Cancer Cell Growth Inhibited by Cucurmosin Alone and in Combination With an Epidermal Growth Factor Receptor–Targeted Drug

Pancreas ◽

10.1097/mpa.0000000000000087 ◽

2014 ◽

Vol 43 (2) ◽

pp. 291-297 ◽

Cited By ~ 6

Author(s):

Congfei Wang ◽

Aiqin Yang ◽

Baoming Zhang ◽

Qiang Yin ◽

Heguang Huang ◽

...

Keyword(s):

Pancreatic Cancer ◽

Growth Factor ◽

Cell Growth ◽

Epidermal Growth Factor ◽

Pancreatic Cancer Cell ◽

Growth Factor Receptor ◽

Cancer Cell Growth ◽

Epidermal Growth ◽

Targeted Drug

Epidermal growth factor receptor-targeted treatment strategies in advanced pancreatic cancer: Is K-RAS mutational testing ready for prime time?

memo - Magazine of European Medical Oncology ◽

10.1007/s12254-011-0302-3 ◽

2011 ◽

Vol 4 (4) ◽

pp. 257-259

Author(s):

T. Bauernhofer

Keyword(s):

Pancreatic Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Advanced Pancreatic Cancer ◽

Treatment Strategies ◽

Growth Factor Receptor ◽

Targeted Treatment ◽

Prime Time ◽

Epigenetic and transcriptional control of the epidermal growth factor receptor (EGFR) regulates the tumor immune microenvironment in pancreatic cancer

Cancer Discovery ◽

10.1158/2159-8290.cd-20-0519 ◽

2020 ◽

pp. CD-20-0519

Author(s):

Jinyang Li ◽

Salina Yuan ◽

Robert J Norgard ◽

Fangxue Yan ◽

Yu H Sun ◽

...

Keyword(s):

Pancreatic Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Transcriptional Control ◽

Growth Factor Receptor ◽

Immune Microenvironment ◽

Tumor Immune Microenvironment ◽